DENTSPLY SIRONA Inc. (XRAY)
USD 18.68
(-2.66%)
USD 18.68
(-2.66%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.08 Billion USD | -1.79% |
| 2022 | 2.12 Billion USD | -9.91% |
| 2021 | 2.36 Billion USD | 42.49% |
| 2020 | 1.65 Billion USD | -23.47% |
| 2019 | 2.16 Billion USD | 4.71% |
| 2018 | 2.06 Billion USD | -5.52% |
| 2017 | 2.18 Billion USD | 9.38% |
| 2016 | 2 Billion USD | 31.88% |
| 2015 | 1.51 Billion USD | -5.16% |
| 2014 | 1.59 Billion USD | 1.42% |
| 2013 | 1.57 Billion USD | 1.35% |
| 2012 | 1.55 Billion USD | 22.22% |
| 2011 | 1.27 Billion USD | 12.68% |
| 2010 | 1.13 Billion USD | 1.7% |
| 2009 | 1.11 Billion USD | -3.53% |
| 2008 | 1.15 Billion USD | 10.68% |
| 2007 | 1.04 Billion USD | 12.03% |
| 2006 | 929.01 Million USD | 6.9% |
| 2005 | 869.01 Million USD | 2.66% |
| 2004 | 846.51 Million USD | 9.48% |
| 2003 | 773.2 Million USD | 5.5% |
| 2002 | 732.89 Million USD | 28.65% |
| 2001 | 569.67 Million USD | 12.82% |
| 2000 | 504.95 Million USD | 7.07% |
| 1999 | 471.6 Million USD | 3.9% |
| 1998 | 453.9 Million USD | 13.14% |
| 1997 | 401.2 Million USD | 13.72% |
| 1996 | 352.8 Million USD | 16.71% |
| 1995 | 302.3 Million USD | 8.82% |
| 1994 | 277.8 Million USD | -0.29% |
| 1993 | 278.6 Million USD | 762.54% |
| 1992 | 32.3 Million USD | 55.29% |
| 1991 | 20.8 Million USD | 82.46% |
| 1990 | 11.4 Million USD | 60.56% |
| 1989 | 7.1 Million USD | 12.7% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 512 Million USD | 1.19% |
| 2024 Q1 | 506 Million USD | -3.07% |
| 2023 Q4 | 522 Million USD | 5.45% |
| 2023 Q1 | 519 Million USD | 0.39% |
| 2023 FY | 2.08 Billion USD | -1.79% |
| 2023 Q3 | 495 Million USD | -10.0% |
| 2023 Q2 | 550 Million USD | 5.97% |
| 2022 Q4 | 517 Million USD | 1.77% |
| 2022 Q3 | 508 Million USD | -12.56% |
| 2022 Q2 | 581 Million USD | 12.82% |
| 2022 Q1 | 515 Million USD | -13.15% |
| 2022 FY | 2.12 Billion USD | -9.91% |
| 2021 Q2 | 598 Million USD | 3.28% |
| 2021 FY | 2.36 Billion USD | 42.49% |
| 2021 Q4 | 593 Million USD | 0.34% |
| 2021 Q1 | 579 Million USD | 1.4% |
| 2021 Q3 | 591 Million USD | -1.17% |
| 2020 Q3 | 442.3 Million USD | 151.16% |
| 2020 FY | 1.65 Billion USD | -23.47% |
| 2020 Q1 | 467.8 Million USD | -23.39% |
| 2020 Q4 | 571 Million USD | 29.1% |
| 2020 Q2 | 176.1 Million USD | -62.36% |
| 2019 FY | 2.16 Billion USD | 4.71% |
| 2019 Q2 | 540.8 Million USD | 8.22% |
| 2019 Q4 | 610.6 Million USD | 18.79% |
| 2019 Q3 | 514 Million USD | -4.96% |
| 2019 Q1 | 499.7 Million USD | -4.78% |
| 2018 Q1 | 514.1 Million USD | -13.35% |
| 2018 Q4 | 524.8 Million USD | 10.23% |
| 2018 Q3 | 476.1 Million USD | -13.87% |
| 2018 FY | 2.06 Billion USD | -5.52% |
| 2018 Q2 | 552.8 Million USD | 7.53% |
| 2017 Q4 | 593.3 Million USD | 6.14% |
| 2017 FY | 2.18 Billion USD | 9.38% |
| 2017 Q3 | 559 Million USD | 2.72% |
| 2017 Q2 | 544.2 Million USD | 10.61% |
| 2017 Q1 | 492 Million USD | -9.14% |
| 2016 FY | 2 Billion USD | 31.88% |
| 2016 Q1 | 418.9 Million USD | 11.8% |
| 2016 Q4 | 541.5 Million USD | 5.43% |
| 2016 Q3 | 513.6 Million USD | -2.52% |
| 2016 Q2 | 526.9 Million USD | 25.78% |
| 2015 FY | 1.51 Billion USD | -5.16% |
| 2015 Q3 | 369.5 Million USD | -7.55% |
| 2015 Q4 | 374.7 Million USD | 1.41% |
| 2015 Q2 | 399.66 Million USD | 7.04% |
| 2015 Q1 | 373.36 Million USD | -5.01% |
| 2014 Q3 | 388.06 Million USD | -8.58% |
| 2014 Q1 | 394.2 Million USD | -0.91% |
| 2014 FY | 1.59 Billion USD | 1.42% |
| 2014 Q4 | 393.05 Million USD | 1.29% |
| 2014 Q2 | 424.46 Million USD | 7.68% |
| 2013 Q1 | 388.2 Million USD | -0.98% |
| 2013 Q2 | 414.95 Million USD | 6.89% |
| 2013 Q3 | 376.41 Million USD | -9.29% |
| 2013 Q4 | 397.83 Million USD | 5.69% |
| 2013 FY | 1.57 Billion USD | 1.35% |
| 2012 Q1 | 392.75 Million USD | 8.81% |
| 2012 Q2 | 407.46 Million USD | 3.75% |
| 2012 Q3 | 364.11 Million USD | -10.64% |
| 2012 Q4 | 392.05 Million USD | 7.67% |
| 2012 FY | 1.55 Billion USD | 22.22% |
| 2011 Q1 | 299.98 Million USD | 4.27% |
| 2011 FY | 1.27 Billion USD | 12.68% |
| 2011 Q4 | 360.95 Million USD | 21.27% |
| 2011 Q3 | 297.64 Million USD | -5.46% |
| 2011 Q2 | 314.85 Million USD | 4.96% |
| 2010 Q2 | 287.59 Million USD | 1.97% |
| 2010 Q3 | 272.81 Million USD | -5.14% |
| 2010 Q4 | 287.71 Million USD | 5.46% |
| 2010 FY | 1.13 Billion USD | 1.7% |
| 2010 Q1 | 282.03 Million USD | -0.82% |
| 2009 Q4 | 284.38 Million USD | -62.9% |
| 2009 FY | 1.11 Billion USD | -3.53% |
| 2009 Q3 | 766.62 Million USD | -4.04% |
| 2009 Q1 | 266.96 Million USD | -1.5% |
| 2009 Q2 | 798.88 Million USD | 199.24% |
| 2008 Q4 | 271.03 Million USD | -3.27% |
| 2008 Q2 | 315.48 Million USD | 10.6% |
| 2008 Q1 | 285.24 Million USD | 4.59% |
| 2008 FY | 1.15 Billion USD | 10.68% |
| 2008 Q3 | 280.18 Million USD | -11.19% |
| 2007 Q4 | 272.73 Million USD | 7.8% |
| 2007 Q1 | 246.27 Million USD | 2.27% |
| 2007 FY | 1.04 Billion USD | 12.03% |
| 2007 Q2 | 268.78 Million USD | 9.14% |
| 2007 Q3 | 252.99 Million USD | -5.88% |
| 2006 FY | 929.01 Million USD | 6.9% |
| 2006 Q4 | 240.81 Million USD | 6.6% |
| 2006 Q3 | 225.91 Million USD | -6.71% |
| 2006 Q2 | 242.15 Million USD | 10.0% |
| 2006 Q1 | 220.13 Million USD | -1.63% |
| 2005 Q2 | 227.28 Million USD | 8.78% |
| 2005 Q3 | 209 Million USD | -8.04% |
| 2005 Q4 | 223.79 Million USD | 7.08% |
| 2005 Q1 | 208.94 Million USD | -9.04% |
| 2005 FY | 869.01 Million USD | 2.66% |
| 2004 Q1 | 204.85 Million USD | 9.67% |
| 2004 Q4 | 229.71 Million USD | 15.41% |
| 2004 Q3 | 199.04 Million USD | -6.51% |
| 2004 Q2 | 212.9 Million USD | 3.93% |
| 2004 FY | 846.51 Million USD | 9.48% |
| 2003 Q1 | 190.07 Million USD | -3.91% |
| 2003 Q4 | 186.78 Million USD | -2.33% |
| 2003 Q3 | 191.23 Million USD | -6.77% |
| 2003 Q2 | 205.11 Million USD | 7.91% |
| 2003 FY | 773.2 Million USD | 5.5% |
| 2002 FY | 732.89 Million USD | 28.65% |
| 2002 Q3 | 179.22 Million USD | -3.4% |
| 2002 Q4 | 197.79 Million USD | 10.36% |
| 2002 Q1 | 170.34 Million USD | -1.96% |
| 2002 Q2 | 185.53 Million USD | 8.91% |
| 2001 Q3 | 132.38 Million USD | -1.0% |
| 2001 Q4 | 173.74 Million USD | 31.24% |
| 2001 Q1 | 136.22 Million USD | 3.59% |
| 2001 Q2 | 133.72 Million USD | -1.83% |
| 2001 FY | 569.67 Million USD | 12.82% |
| 2000 Q4 | 131.5 Million USD | 7.07% |
| 2000 Q3 | 122.81 Million USD | -5.07% |
| 2000 Q2 | 129.38 Million USD | 6.7% |
| 2000 Q1 | 121.25 Million USD | -3.69% |
| 2000 FY | 504.95 Million USD | 7.07% |
| 1999 Q3 | 116.3 Million USD | -0.77% |
| 1999 FY | 471.6 Million USD | 3.9% |
| 1999 Q1 | 112.2 Million USD | -9.37% |
| 1999 Q2 | 117.2 Million USD | 4.46% |
| 1999 Q4 | 125.9 Million USD | 8.25% |
| 1998 Q3 | 112.6 Million USD | -0.35% |
| 1998 Q4 | 123.8 Million USD | 9.95% |
| 1998 FY | 453.9 Million USD | 13.14% |
| 1998 Q1 | 104.4 Million USD | -5.52% |
| 1998 Q2 | 113 Million USD | 8.24% |
| 1997 Q2 | 98.9 Million USD | 3.02% |
| 1997 FY | 401.2 Million USD | 13.72% |
| 1997 Q4 | 110.5 Million USD | 15.22% |
| 1997 Q3 | 95.9 Million USD | -3.03% |
| 1997 Q1 | 96 Million USD | -2.74% |
| 1996 Q2 | 88.8 Million USD | 5.84% |
| 1996 FY | 352.8 Million USD | 16.71% |
| 1996 Q4 | 98.7 Million USD | 21.55% |
| 1996 Q3 | 81.2 Million USD | -8.56% |
| 1996 Q1 | 83.9 Million USD | -2.78% |
| 1995 FY | 302.3 Million USD | 8.82% |
| 1995 Q4 | 86.3 Million USD | 24.53% |
| 1995 Q3 | 69.3 Million USD | -8.21% |
| 1995 Q2 | 75.5 Million USD | 6.04% |
| 1995 Q1 | 71.2 Million USD | -1.11% |
| 1994 FY | 277.8 Million USD | -0.29% |
| 1994 Q1 | 69.8 Million USD | -8.76% |
| 1994 Q2 | 72 Million USD | 3.15% |
| 1994 Q3 | 70.6 Million USD | -1.94% |
| 1994 Q4 | 72 Million USD | 1.98% |
| 1993 FY | 278.6 Million USD | 762.54% |
| 1993 Q4 | 76.5 Million USD | 14.01% |
| 1993 Q3 | 67.1 Million USD | -4.01% |
| 1993 Q2 | 69.9 Million USD | 281.97% |
| 1993 Q1 | 18.3 Million USD | -1.08% |
| 1992 Q2 | 11.9 Million USD | 25.26% |
| 1992 FY | 32.3 Million USD | 55.29% |
| 1992 Q3 | 16.6 Million USD | 39.5% |
| 1992 Q4 | 18.5 Million USD | 11.45% |
| 1992 Q1 | 9.5 Million USD | 11.76% |
| 1991 Q2 | 6.8 Million USD | -1.45% |
| 1991 Q3 | 7.5 Million USD | 10.29% |
| 1991 FY | 20.8 Million USD | 82.46% |
| 1991 Q1 | 6.9 Million USD | 0.0% |
| 1991 Q4 | 8.5 Million USD | 13.33% |
| 1990 Q4 | 6.9 Million USD | 68.29% |
| 1990 FY | 11.4 Million USD | 60.56% |
| 1990 Q3 | 4.1 Million USD | 36.67% |
| 1990 Q2 | 3 Million USD | 11.11% |
| 1990 Q1 | 2.7 Million USD | -10.0% |
| 1989 Q4 | 3 Million USD | 7.14% |
| 1989 Q1 | 4.6 Million USD | -6.12% |
| 1989 Q3 | 2.8 Million USD | -6.67% |
| 1989 Q2 | 3 Million USD | -34.78% |
| 1989 FY | 7.1 Million USD | 12.7% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -3604.822% |
| AngioDynamics, Inc. | 154.69 Million USD | -1248.434% |
| AtriCure, Inc. | 300.37 Million USD | -594.477% |
| Avinger, Inc. | 2 Million USD | -104043.784% |
| Azenta, Inc. | 263.14 Million USD | -692.734% |
| BioLife Solutions, Inc. | 46.75 Million USD | -4361.841% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 11.531% |
| Daxor Corporation | 1.1 Million USD | -188945.168% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -22876.099% |
| Femasys Inc. | 691.9 Thousand USD | -301388.219% |
| GlucoTrack, Inc. | -13 Thousand USD | 16046253.846% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -3327.201% |
| Hologic, Inc. | 2.22 Billion USD | 6.365% |
| ICU Medical, Inc. | 739.87 Million USD | -181.94% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 55.894% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -12384.826% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -1541.886% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1748208.172% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1748208.172% |
| Masimo Corporation | 1 Billion USD | -107.872% |
| Microbot Medical Inc. | -106 Thousand USD | 1968024.528% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -6203.067% |
| Merit Medical Systems, Inc. | 583.87 Million USD | -257.27% |
| Nephros, Inc. | 8.4 Million USD | -24718.56% |
| NovoCure Limited | 381.05 Million USD | -447.423% |
| NEXGEL, Inc. | 619 Thousand USD | -336895.153% |
| NEXGEL, Inc. | 619 Thousand USD | -336895.153% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 373935.125% |
| OraSure Technologies, Inc. | 179.42 Million USD | -1062.629% |
| Pro-Dex, Inc. | 14.55 Million USD | -14235.784% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 172925.186% |
| Predictive Oncology Inc. | 1.14 Million USD | -182036.162% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -35879.307% |
| QuidelOrtho Corporation | 1.49 Billion USD | -39.588% |
| Repligen Corporation | 315.22 Million USD | -561.743% |
| Sanara MedTech Inc. | 57.13 Million USD | -3550.864% |
| STAAR Surgical Company | 252.65 Million USD | -725.645% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 234153.821% |
| Utah Medical Products, Inc. | 30.03 Million USD | -6844.537% |
| Jin Medical International Ltd. | 6.78 Million USD | -30645.041% |